Trial
NCT04537299
COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: HIGH
Sponsor
Mayo Clinic
Collaborators
National Institute on Aging (NIA)
Condition
Covid19
Intervention
Fisetin
Why stopped
The DSMB and NIA determined the study should be stopped due to futility.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-08-26